Evidence map›Paper›PMID 35384348›Full record

ArticleClinical and translational medicine2022

Partial restoration of gut-mucosal dysbiosis in late-treated HIV-infected subjects with CD4 T-cell recovery.

Israel Olivas-Martínez, Isaac Rosado-Sánchez, Juan Antonio Cordero-Varela, Salvador Sobrino, Miguel Genebat, Inés Herrero-Fernández, Rocío Martínez de Pablos, Ana Eloísa Carvajal, Rocío Ruiz, Ana Isabel Álvarez-Ríos and 6 more

Open access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Israel Olivas-MartínezImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Isaac Rosado-SánchezImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Juan Antonio Cordero-VarelaBioinformatics and Computational Biology Service, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Salvador SobrinoDigestive Service, University Hospital Virgen del Rocío, Seville, Spain.
Miguel GenebatImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Inés Herrero-FernándezImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Rocío Martínez de PablosBiochemistry and Molecular Biology Department, Pharmacy, University of Seville, Spain; Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Ana Eloísa CarvajalBiochemistry and Molecular Biology Department, Pharmacy, University of Seville, Spain; Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Rocío RuizBiochemistry and Molecular Biology Department, Pharmacy, University of Seville, Spain; Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Ana Isabel Álvarez-RíosBiochemistry Service, University Hospital Virgen del Rocío, Seville, Spain.
María Fontillón-AlberdiService of Pathological Anatomy, University Hospital Virgen del Rocío, Seville, Spain.
Ángel Bulnes-RamosImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Vanesa Garrido-RodríguezImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
María Del Mar Pozo-BaladoImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
Manuel LealInternal Medicine Service, Viamed-Santa Ángela Hospital, Seville, Spain.
Yolanda María PachecoImmunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.ORCID 0000-0002-9451-8083
Instituto de Biomedicina de Sevilla · ESHospital Universitario Virgen del Rocío · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DysbiosisHIV InfectionsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCD4-Positive T-LymphocytesHumans

Identifiers

PMID35384348
PMCPMC8982320
OpenAlexW4223618946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.